103 related articles for article (PubMed ID: 15468758)
1. Statistical methods for analyzing tissue microarray data.
Liu X; Minin V; Huang Y; Seligson DB; Horvath S
J Biopharm Stat; 2004 Aug; 14(3):671-85. PubMed ID: 15468758
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarrays: emerging standard for biomarker validation.
Hassan S; Ferrario C; Mamo A; Basik M
Curr Opin Biotechnol; 2008 Feb; 19(1):19-25. PubMed ID: 18053705
[TBL] [Abstract][Full Text] [Related]
3. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
[TBL] [Abstract][Full Text] [Related]
4. [Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma].
Merseburger AS; Hennenlotter J; Schilling D; Sievert KD; Küfer R; Kuczyk MA
Urologe A; 2006 Mar; 45(3):323-4, 326-7. PubMed ID: 16465523
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
Burczynski ME; Twine NC; Dukart G; Marshall B; Hidalgo M; Stadler WM; Logan T; Dutcher J; Hudes G; Trepicchio WL; Strahs A; Immermann F; Slonim DK; Dorner AJ
Clin Cancer Res; 2005 Feb; 11(3):1181-9. PubMed ID: 15709187
[TBL] [Abstract][Full Text] [Related]
6. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
7. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.
Merseburger AS; Serth J; von der Heyde E; Kobierski A; Wegener U; Mengel M; Jonas U; Kuczyk M
Urol Int; 2007; 79(2):164-9. PubMed ID: 17851288
[TBL] [Abstract][Full Text] [Related]
9. TmaDB: a repository for tissue microarray data.
Sharma-Oates A; Quirke P; Westhead DR
BMC Bioinformatics; 2005 Sep; 6():218. PubMed ID: 16137321
[TBL] [Abstract][Full Text] [Related]
10. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
11. Evaluating methods for classifying expression data.
Man MZ; Dyson G; Johnson K; Liao B
J Biopharm Stat; 2004 Nov; 14(4):1065-84. PubMed ID: 15587980
[TBL] [Abstract][Full Text] [Related]
12. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling predicts survival in conventional renal cell carcinoma.
Zhao H; Ljungberg B; Grankvist K; Rasmuson T; Tibshirani R; Brooks JD
PLoS Med; 2006 Jan; 3(1):e13. PubMed ID: 16318415
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma.
Yoo KH; Park YK; Kim HS; Jung WW; Chang SG
Pathol Int; 2010 Oct; 60(10):661-6. PubMed ID: 20846263
[TBL] [Abstract][Full Text] [Related]
15. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers for predicting prognosis of renal cell carcinoma.
Nogueira M; Kim HL
Urol Oncol; 2008; 26(2):113-24. PubMed ID: 18312928
[TBL] [Abstract][Full Text] [Related]
17. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
18. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
Verh Dtsch Ges Pathol; 1999; 83():225-32. PubMed ID: 10714215
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
20. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
